The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India

por Babu, Govind, Saldanha, Smitha Carol, Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah, Jacob, Linu Abraham, Mallekavu, Suresh Babu, Dasappa, Loknatha, Kiran, Pretesh Rohan, Sreevatsa, Aparna, Appachu, Sandhya, Unnikrishnan, Vineetha, Arroju, Venugopal
Publicado 2016